Pablo Corral on Why Early LDL-C Reduction Saves Lives
Pablo Corral, Pharmacology Professor at FASTA University, Past President of Argentine Lipid Society, shared on LinkedIn:
”Statins:
- The Power of Early Intervention and the Reality of the Legacy Effect
- The long arc of cardiovascular prevention continues to point in one direction: earlier LDL-C reduction delivers deeper, long-lasting protection. Two landmark analyses reinforce this principle with remarkable clarity.
The Scandinavian Simvastatin Survival Study (4S)—now revisited three decades after its publication—established that intensive LDL-C lowering not only reduces cardiovascular events but fundamentally alters long-term disease trajectories.
Its impact initiated a paradigm shift in dyslipidaemia management that persists today. (10.1016/S0140-6736(24)02089-0)
The ASCOT-Legacy 20-year follow-up extends this insight even further.
Despite convergence of lipid levels after trial completion, participants originally randomised to atorvastatin maintained significant long-term reductions in non-fatal myocardial infarction, fatal coronary heart disease, total coronary events, and cardiovascular mortality—demonstrating a true “legacy effect.”
Each 1 mmol/L lower in-trial LDL-C was associated with substantial long-term reductions in cardiovascular and all-cause mortality. (10.1136/heartjnl-2024-325104)
Key message:
- Statins do more than lower LDL-C today—they reduce the cumulative cholesterol burden that determines tomorrow’s risk.
- Starting earlier, treating consistently, and achieving lower LDL-C levels is not aggressive medicine—it is simply good medicine.
As the evidence mounts, the clinical imperative becomes harder to ignore:
Delay is costly.
Early, sustained lipid-lowering therapy saves lives.”
Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers